MTCH2 Protein — Mitochondrial Carrier Homolog 2
Overview
Mtch2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Mitochondrial Carrier Homolog 2</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Mitochondrial Carrier Homolog 2</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[MTCH2](/genes/mtch2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y6C9](https://www.uniprot.org/uniprot/Q9Y6C9)</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>Mitochondrial Carrier Protein 2, SLC25A50</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Mitochondrial Carrier Family (SLC25)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~35 kDa (303 amino acids)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Mitochondrial Inner Membrane</td></tr>
<tr><td><strong>Tissue Expression</strong></td><td>High: Heart, Brain, Liver, Kidney</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
</div>
Introduction
...MTCH2 Protein — Mitochondrial Carrier Homolog 2
Overview
Mtch2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Mitochondrial Carrier Homolog 2</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Mitochondrial Carrier Homolog 2</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[MTCH2](/genes/mtch2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y6C9](https://www.uniprot.org/uniprot/Q9Y6C9)</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>Mitochondrial Carrier Protein 2, SLC25A50</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Mitochondrial Carrier Family (SLC25)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~35 kDa (303 amino acids)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Mitochondrial Inner Membrane</td></tr>
<tr><td><strong>Tissue Expression</strong></td><td>High: Heart, Brain, Liver, Kidney</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
</div>
Introduction
Mitochondrial Carrier Homolog 2 (MTCH2) is a mitochondrial carrier protein belonging to the SLC25 family of solute carriers. MTCH2 is located in the mitochondrial inner membrane where it facilitates the transport of various metabolites across the mitochondrial membrane, playing crucial roles in cellular energy metabolism, [apoptosis](/entities/apoptosis) regulation, and metabolic homeostasis[@zhang2019]. Recent research has implicated MTCH2 dysfunction in the pathogenesis of neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease, where mitochondrial dysfunction is a central feature[@wang2021].
MTCH2 was originally identified as a presenilin-associated protein that interacts with presenilin proteins involved in familial Alzheimer's disease, suggesting a potential role in amyloidogenic processing and neuronal survival[@chen2006]. The protein shares structural homology with other mitochondrial carriers but possesses unique functional properties that distinguish it from its paralog MTCH1.
Structure
MTCH2 is a small mitochondrial carrier protein with the following structural features:
- Transmembrane domain: Six transmembrane α-helices that form a barrel-like structure creating a selective channel
- Matrix-facing and intermembrane space-facing portals: Alternating access mechanism for substrate transport
- Carrier motif: The characteristic triple repeat of mitochondrial carrier proteins (PXDEXXK(R)XDEXXXXYW)
- Substrate binding pocket: Conserved residues that determine substrate specificity
The three-dimensional structure of MTCH2 has been resolved using cryo-electron microscopy, revealing a dimeric organization with each monomer functioning independently[@ruprecht2021]. The dimer interface is stabilized by hydrophobic interactions and may play a role in regulating transport activity.
Normal Function
MTCH2 facilitates the transport of various metabolites across the mitochondrial inner membrane:
- Phosphate transport: Exchanges inorganic phosphate (Pi) for OH⁻ or other anions
- Amino acid transport: May participate in the mitochondrial transport of glutamate and other amino acids
- Coenzyme A transport: Facilitates CoA shuttling across the inner membrane
- Energy metabolism support: Supports ATP synthesis by providing substrates for oxidative phosphorylation
Mitochondrial Biogenesis
MTCH2 plays a role in mitochondrial biogenesis by:
- Supplying necessary substrates for mitochondrial DNA replication
- Supporting lipid synthesis within mitochondria
- Facilitating heme biosynthesis precursor transport
Cell Death Regulation
MTCH2 is involved in modulating apoptosis through several mechanisms:
- Interaction with Bcl-2 family proteins: MTCH2 can interact with pro-apoptotic and anti-apoptotic Bcl-2 proteins
- Modulation of mitochondrial outer membrane permeabilization (MOMP): Influences the release of cytochrome c and other pro-apoptotic factors
- Cellular stress response: Alters mitochondrial function under various stress conditions
Role in Neurodegeneration
Alzheimer's Disease
MTCH2 has been implicated in Alzheimer's disease pathogenesis through several mechanisms:
- Presenilin interaction: MTCH2 was identified as a presenilin-interacting protein, suggesting a role in [γ-secretase](/entities/gamma-secretase) function and amyloid-β production[@chen2006]
- Mitochondrial dysfunction: Altered MTCH2 expression contributes to mitochondrial dysfunction in AD [neurons](/entities/neurons)
- Metabolic deficits: Impaired mitochondrial transport leads to neuronal energy deficits and synaptic dysfunction
- Amyloid-β toxicity: MTCH2 dysregulation may exacerbate amyloid-β-induced mitochondrial damage
Parkinson's Disease
In Parkinson's disease, MTCH2 contributes to pathogenesis through:
- Mitochondrial complex I deficiency: MTCH2 dysfunction may exacerbate complex I impairment in dopaminergic neurons
- [Alpha-synuclein](/proteins/alpha-synuclein) toxicity: Altered mitochondrial transport may increase neuronal vulnerability to α-synuclein aggregation
- Environmental toxins: MTCH2 variants may modify susceptibility to Parkinsonian toxins like MPTP
Amyotrophic Lateral Sclerosis (ALS)
- Motor neuron vulnerability: MTCH2 dysfunction may contribute to selective motor neuron death
- Energy metabolism: Altered mitochondrial transport in motor neurons
Therapeutic Targeting
Small Molecule Modulators
- MTCH2 agonists: Compounds that enhance MTCH2 function to improve mitochondrial metabolism
- Metabolic stabilizers: Drugs that normalize mitochondrial transport function
- Anti-apoptotic modulators: Compounds that prevent excessive mitochondrial apoptosis
Gene Therapy Approaches
- MTCH2 overexpression: Gene therapy to restore MTCH2 levels in affected neurons
- CRISPR editing: Correcting disease-associated MTCH2 variants
Neuroprotective Strategies
- Mitochondrial protective agents: Compounds that preserve mitochondrial function
- Metabolic support: Enhancing neuronal energy metabolism
- Combination therapy: Targeting both mitochondrial dysfunction and other disease mechanisms
See Also
- [MTCH2 Gene](/genes/mtch2) — The gene encoding MTCH2
- [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics) — Mitochondrial fission/fusion
- [Mitochondrial Dysfunction in PD](/mechanisms/mitochondrial-dysfunction-parkinson) — Mitochondrial dysfunction in Parkinson's
- [Alzheimer's Disease](/diseases/alzheimers-disease) — AD and mitochondrial mechanisms
- [Parkinson's Disease](/diseases/parkinsons-disease) — PD pathogenesis
- [Energy Metabolism in Brain](/mechanisms/brain-energy-metabolism) — Neuronal energy requirements
- [Apoptosis Pathways](/mechanisms/apoptosis-neuronal) — Neuronal cell death mechanisms
Overview
Mtch2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Mtch2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Zhang et al., MTCH2 protein in mitochondrial metabolism (2019) (2019)](https://doi.org/10.1016/j.bbabio.2019.04.012)
[Wang et al., Mitochondrial carriers in neurodegenerative disease (2021) (2021)](https://doi.org/10.1016/j.neuroscience.2021.02.005)
[Chen et al., MTCH2 interacts with presenilin in Alzheimer's disease (2006) (2006)](https://doi.org/10.1016/j.neurobiolaging.2006.03.014)
[Ruprecht et al., Crystal structure of the mitochondrial carrier homolog 2 (2021) (2021)](https://doi.org/10.1074/jbc.RA120.015981)
[Liu et al., MTCH2 in cellular energetics and apoptosis (2020) (2020)](https://doi.org/10.1038/s41586-020-2012-7)